Talis Biomedical Statistics
Total Valuation
TLIS has a market cap or net worth of $16.19 million. The enterprise value is -$40.87 million.
| Market Cap | 16.19M |
| Enterprise Value | -40.87M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TLIS has 1.82 million shares outstanding. The number of shares has increased by 0.95% in one year.
| Shares Outstanding | 1.82M |
| Shares Change (YoY) | +0.95% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 8.31% |
| Owned by Institutions (%) | 43.93% |
| Float | 1.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.59 |
| Forward PS | n/a |
| PB Ratio | 0.23 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.86, with a Debt / Equity ratio of 0.28.
| Current Ratio | 8.86 |
| Quick Ratio | 8.75 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -69.50% and return on invested capital (ROIC) is -75.26%.
| Return on Equity (ROE) | -69.50% |
| Return on Assets (ROA) | -54.20% |
| Return on Capital (ROIC) | -75.26% |
| Revenue Per Employee | $21,556 |
| Profits Per Employee | -$626,333 |
| Employee Count | 99 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.87% in the last 52 weeks. The beta is 1.74, so TLIS's price volatility has been higher than the market average.
| Beta (1Y) | 1.74 |
| 52-Week Price Change | +27.87% |
| 50-Day Moving Average | 8.49 |
| 200-Day Moving Average | 7.28 |
| Relative Strength Index (RSI) | 58.99 |
| Average Volume (30 Days) | 9,077 |
Short Selling Information
The latest short interest is 13,304, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 13,304 |
| Short Previous Month | 13,932 |
| Short % of Shares Out | 0.73% |
| Short % of Float | 1.31% |
| Short Ratio (days to cover) | 1.84 |
Income Statement
In the last 12 months, TLIS had revenue of $2.13 million and -$62.01 million in losses. Loss per share was -$34.12.
| Revenue | 2.13M |
| Gross Profit | 2.09M |
| Operating Income | -66.82M |
| Pretax Income | -62.01M |
| Net Income | -62.01M |
| EBITDA | -56.93M |
| EBIT | -62.01M |
| Loss Per Share | -$34.12 |
Balance Sheet
The company has $76.73 million in cash and $19.67 million in debt, giving a net cash position of $57.06 million or $31.37 per share.
| Cash & Cash Equivalents | 76.73M |
| Total Debt | 19.67M |
| Net Cash | 57.06M |
| Net Cash Per Share | $31.37 |
| Equity / Book Value | 69.12M |
| Book Value Per Share | 38.00 |
| Working Capital | 68.91M |
Cash Flow
In the last 12 months, operating cash flow was -$53.24 million and capital expenditures -$486,000, giving a free cash flow of -$53.73 million.
| Operating Cash Flow | -53.24M |
| Capital Expenditures | -486,000 |
| Free Cash Flow | -53.73M |
| FCF Per Share | -$29.56 |
Margins
Gross margin is 98.08%, with operating and profit margins of -3,130.97% and -2,905.67%.
| Gross Margin | 98.08% |
| Operating Margin | -3,130.97% |
| Pretax Margin | -2,905.67% |
| Profit Margin | -2,905.67% |
| EBITDA Margin | -2,667.90% |
| EBIT Margin | -2,905.67% |
| FCF Margin | -2,517.62% |
Dividends & Yields
TLIS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.95% |
| Shareholder Yield | -0.95% |
| Earnings Yield | -383.01% |
| FCF Yield | -331.86% |
Analyst Forecast
The average price target for TLIS is $5.00, which is -43.82% lower than the current price. The consensus rating is "Strong Sell".
| Price Target | $5.00 |
| Price Target Difference | -43.82% |
| Analyst Consensus | Strong Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 6, 2023. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jul 6, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
TLIS has an Altman Z-Score of -8.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.87 |
| Piotroski F-Score | 3 |